Barclays chief executive to undergo treatment for cancer

Barclays has announced that its chief executive, CS Venkatakrishnan, has been diagnosed with non-Hodgkin lymphoma and will be undergoing treatment for the next 12 to 16 weeks.

In a letter to staff, Venkatakrishnan wrote: “The doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen. This is likely to last 12 to 16 weeks.”

He added: “During this period, the company will run normally, and I will continue to be actively engaged in managing it. However, I will have to work from home for some periods and not be able to travel.”

He will be treated at the Memorial Sloan Kettering Cancer Center in New York.

More updates to come